Home
>
US Stocks
>
Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc
IOVA

Iovance Biotherapeutics Inc (IOVA)

$25.6110.96%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
26.22
Today Low/High
25.36 / 26.22
52 Week Low/High
$15.88 / $54.21
Market Cap
$3.29B

Company Details

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in pivotal programs in patients with metastatic melanoma and cervical cancer. In addition, the company's TIL therapy is being investigated in a registration-supporting study for the treatment of patients with locally advanced, recurrent or metastatic non-small cell lung cancer. Clinical studies are also underway to evaluate TIL in earlier stage cancers in combination with currently approved treatments, and to investigate Iovance peripheral blood lymphocyte (PBL) T cell therapy for blood cancers.
Organisation
Iovance Biotherapeutics Inc
Headquaters
San Carlos, California, US
Employees
241
Industry
Health Technology
CEO
Maria Fardis

Discover more

Frequently Asked Questions

What is Iovance Biotherapeutics Inc (IOVA) share price today?

Can Indians buy Iovance Biotherapeutics Inc (IOVA) shares?

How can I buy Iovance Biotherapeutics Inc (IOVA) shares from India?

Can Fractional shares of Iovance Biotherapeutics Inc (IOVA) be purchased?

What are the documents required to start investing in Iovance Biotherapeutics Inc (IOVA) stocks?

We are a SEBI registered investement advisor